Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03428399 · ClinicalTrials.gov registry record

Depression and Body Image Distress Following Mastectomy With Reconstruction

A clinical trial, sponsored by Massachusetts General Hospital.

Completed
Registry status
51
Enrollment target

NCT03428399: Completed study, sponsored by Massachusetts General Hospital.

NCT03428399 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03428399 has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
51 participants
Enrollment target

Study Summary

Mastectomy is a major surgery that can have a profound effect on women's psychosocial wellbeing, including elevated depression and body image distress. Reconstructive breast surgery aims to improve patients' psychosocial adjustment to mastectomy, yet for some women substantial distress persists after reconstruction. However, very little is known about risk or protective factors for persistent depression or body image distress following mastectomy with reconstruction. The present study aims to address this critical gap. In women undergoing mastectomy with breast reconstruction, the investigators will assess risk and protective factors for post-surgery depression severity and body image distress.

Interventions

  • OTHER Psychosocial variables

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2017-10-12
Est. Completion 2021-05-03

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03428399

The ClinicalTrials.gov registry entry for NCT03428399 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Psychosocial variables is the first listed.

NCT03428399 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03428399 about?

NCT03428399 is a clinical study titled "Depression and Body Image Distress Following Mastectomy With Reconstruction". Mastectomy is a major surgery that can have a profound effect on women's psychosocial wellbeing, including elevated depression and body image distress. Reconstructive breast surgery aims to improve patients' psychosocial adjustment to mastectomy, yet for some women substantial distress persists afte...

What is the current status of trial NCT03428399?

This trial is currently completed. The enrollment target is 51 participants. The study started on 2017-10-12. Estimated completion is 2021-05-03.

What interventions are being tested in trial NCT03428399?

The interventions under investigation include: Psychosocial variables (OTHER).

Who is sponsoring clinical trial NCT03428399?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.